Skip to main navigation Skip to search Skip to main content

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma

  • R. S. McNeill
  • , D. A. Canoutas
  • , T. J. Stuhlmiller
  • , H. D. Dhruv
  • , D. M. Irvin
  • , R. E. Bash
  • , S. P. Angus
  • , L. E. Herring
  • , J. M. Simon
  • , K. R. Skinner
  • , J. C. Limas
  • , X. Chen
  • , R. S. Schmid
  • , M. B. Siegel
  • , A. E. Van Swearingen
  • , M. J. Hadler
  • , E. P. Sulman
  • , J. N. Sarkaria
  • , C. K. Anders
  • , L. M. Graves
  • M. E. Berens, G. L. Johnson, C. R. Miller

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalNeuro-Oncology
Volume19
DOIs
StatePublished - Jan 1 2017

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this